Global infertility treatment devices to hit $2.5b by 2032

Its growth is attributed to ongoing innovation, particularly in AI integration.

The global infertility treatment devices market is expected to reach $2.5b by 2032 at a compound annual growth rate of 8.3%, according to Research and Markets.

The sector’s expansion is attributed to ongoing innovation, particularly in the integration of artificial intelligence and the development of environmentally sustainable, cost-effective device designs.

“Leading entities such as Guangzhou Shanshan Medical Apparatus & Instrument Industry Co Ltd and Fertility Basics Inc have secured their market positions through the collective filing of over 2,700 patents,” the report said.

Such organisations are focusing on smart monitoring systems, automation technologies, and advanced material uses.